                UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 
                      TOXIC SUBSTANCES CONTROL ACT (TSCA)
                SCIENCE ADVISORY COMMITTEE ON CHEMICALS (SACC)

                                June 8 - 11, 2020, Meeting
                        Ad Hoc Peer Reviewer Biographical Sketches
                        Docket Number: EPA-HQ-OPPT-2019-0501

                               
Kenny S. Crump

Affiliation: No current affiliation.

Expertise: Research in developing and applying statistical methods for quantitative assessment of health risks from exposures to toxic substances. 

Education: 	PhD in Mathematics, Montana State University, Bozeman, Montana; 
BA in Mathematics, University of Denver, Denver, Colorado; 
BS in Electrical Engineering, Louisiana Tech University, Ruston, Louisiana.

Experience Summary: Dr. Kenny Crump worked for various consulting firms (1980-2010), focusing on developing and applying statistical methods to bioassay data and epidemiological data on risks to health from exposures to toxic substances. Prior to that time, he spent 14 years (1966-1980) teaching mathematics and conducting research at Louisiana Tech University. He is currently conducting unfunded research. He is a Fellow of both the American Statistical Association and the Society for Risk Analysis and received distinguished achievement awards from both of these organizations. He is an author of more than 150 peer reviewed publications and book chapters. 

Panel Experience: Dr. Crump has served on six National Academy of Science Committees (1979-1980, 1981-1982, 1989-1993, 2006-2009, 2014, 2015-2017); EPA's Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Scientific Advisory Panel (SAP) on glyphosate (2016-2017); Health Canada Chrysotile Asbestos Expert Panel (2007-2008); National Toxicology Program Board of Scientific Counselors (2005-2008); EPA Dioxin Reassessment Review Committee (2000-2001); Joint Food and Agricultural Organization and the World Health Organization (FAO/WHO) Expert Committee on Food Additives (JECFA) (2001); Office of Science and Technology Policy Workshop on Methylmercury Statistics Panel (1998); California EPA Office of Environmental Health Hazard Assessment (OEHHA) Risk Assessment Methodology Review Committee (1995-1996); Royal Society of Canada Expert Panel on Asbestos (1996); Mickey Leland National Urban Air Toxics Research Center Science Advisory Panel (1995-1999); National Institute of Environmental Health Sciences Board of Scientific Counselors (1995); National Center for Toxicological Research Science Advisory Board (1991-1995); EPA Research Strategies Advisory Committee (1995-1997); Province of Ontario Advisory Panel on 2,4-Dichlorophenoxyacetic acid (1984-1987); EPA's Science Advisory Board (SAB) (1991-1997); and U. S. Congress Office of Technology Assessment Tolerance Advisory Panel  --  Environmental Contaminants in Food (1978-1979).







                              Jeffrey I. Everitt

Affiliation: Professor of Pathology at the Duke University School of Medicine; Durham, North Carolina.

Expertise: Experimental, veterinary and toxicologic pathology; pulmonary toxicology; particle-induced pulmonary disease.

Education: 	DVM, Cornell University, Ithaca, New York;
            BS, Biological Sciences, Cornell University, Ithaca, New York; 
Residency in anatomic veterinary pathology at the University of Pennsylvania, Philadelphia, Pennsylvania

Experience Summary: Dr. Jeffery Everitt is Professor of Pathology at the Duke University School of Medicine where he provides research animal pathology support to the biomedical community. He is a Diplomate of the American College of Veterinary Pathologists and the American College of Laboratory Animal Medicine, and a Fellow of the International Academy of Toxicologic Pathology. Prior to joining Duke University in 2015, Dr. Everitt served as a Director of Comparative Medicine at GlaxoSmithKline Pharmaceutical R&D (2002-2015) and as a Senior Scientist at the Chemical Industry Institute of Toxicology (CIIT) Centers for Health Research in Research Triangle Park, NC (1985-2002). Dr. Everitt served for two terms (2004-2010) as a member of the Council of the Institute of Laboratory Animal Research (ILAR), National Academies of Science. He has served on editorial boards for the following journals: Toxicological Sciences (2004-2019); Inhalation Toxicology (2004-2009); Toxicologic Pathology (1997-2003 and 2017-present); Veterinary Pathology (1998-2001); Journal of the American Association for Laboratory Animal Science (1997-present); and Comparative Medicine (1997-present). Over the past twenty-five years Dr. Everitt has held committee and leadership positions in a variety of professional organizations in toxicology, pathology and laboratory animal medicine.

Panel Experience: Dr. Everitt has had long-standing peer review experience as a member of pathology working groups at the National Toxicology Program (NTP) (>20 panels since 1985). He has also served as an ad hoc member of the Board of Scientific Counselors of the NTP (2015). In addition, Dr. Everitt has served as a member or chairperson of multiple Special Emphasis Panels for National Institutes of Health (NIH) and National Institute of Environmental Health Sciences (NIEHS) between 2005 and 2014. He served as a member of the EPA, Science Advisory Board Asbestos Committee (2008-2011); the EPA SAB Libby Amphibole Asbestos Review Panel (2012); as an ad hoc member of EPA's Food Quality Protection Act Science Advisory Panel  (2000-2002); and on EPA's Environmental Health Committee SAB (2004-2006). In 2004 Dr. Everitt served on a peer review panel of synthetic vitreous fibers for the Agency for Toxic Substances and Disease Registry (ATSDR) and the EPA. In 1996 and in 2001, Dr. Everitt served as a member of fiber carcinogenesis working groups at the International Agency for Research on Cancer (IARC). In addition to this service in toxicology, Dr. Everitt has served on multiple panels and working groups for academic and private concerns in pathology, toxicology and laboratory animal science.


                                Robert Herrick

Affiliation: Retired, formerly Senior Lecturer, Harvard University School of Public Health, Boston, MA.

Expertise: Occupational and environmental exposure assessment.

Education: 	DS in Environmental Health Sciences, Harvard University, Cambridge, Massachusetts;
            MS in Environmental Health Science, University of Michigan, Ann Arbor, Michigan;
BA in Chemistry, College of Wooster, Wooster, Ohio.

Experience Summary: Dr. Herrick is retired from the Harvard University School of Public Health where he was a faculty member from 1994 to 2018. In this position he conducted research and taught courses on exposure assessment and control to chemicals in the workplace and the general environment. Prior to that he was a researcher on occupational exposures at the National Institute for Occupational Safety and Health (NIOSH) (1977-1994). His workshop activities include the planning committee for the Tenth Surgeon General's Conference on Agricultural Safety and Health (1990-1993); planning committee for the International Conference on Retrospective Exposure Assessment in Occupational Epidemiology (1994); planning committee for the International Conference on Methodological Challenges to the Study of Occupational Injury  -  An International Epidemiology Workshop (1996); working group to prepare IARC Monograph on some non-heterocyclic polycyclic hydrocarbons and some related industrial exposures (2005); Chair, organizing committee for conference: Innovations in Exposure Assessment (2009). His primary research interest is exposure assessment for epidemiologic studies.

Panel Experience: Major panel and committee experience includes: Chair, Institute of Medicine, National Academy report Post-Vietnam Dioxin Exposure in Agent Orange-Contaminated C-123 Aircraft, (2014); Reviewer, Institute of Medicine, National Academy of Sciences reports Veterans and Agent Orange, Update (2004), and Evaluation of the Presumptive Disability Decision-Making Process for Veterans, (2007); Member, Review Panel for the NIOSH National Exposures at Work Survey (NEWS), (2001-2004); Member, Benzene Health Research Project, Scientific Review Panel, American Petroleum Institute (2001-2010); Member, Science Review Board for the FQPA, EPA, (2000-2002); Member, Review Panel for protocol Anthrax Dispersion Study at American Media Incorporated: Characterization of an Indoor Environment Contaminated with Anthrax Spores, Agency for Toxic Substances and Disease Registry (2002); Member, Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides, Institute of Medicine, National Academy of Sciences (1997-2003); Participant, review panel  Exposure Limits to the Chemical Warfare Agent VX, Center for Environmental Health, CDC, USPHS (1987); Participant, workshop to review EPA Exposure Assessment Initiative (1984).
                              Michael A. Jayjock

Affiliation: Sole Proprietor of Jayjock Associates, LLC, Langhorne, Pennsylvania. 

Expertise: Human health exposure/risk assessment; exposure modeling; dose response modeling.

Education: 	PhD and MS in Environmental Engineering, Drexel University, Philadelphia, Pennsylvania;
	BS in Secondary Education, Penn State University, State College, Pennsylvania.

Experience Summary: Dr. Michael Jayjock is an independent consultant who retired as a Senior Research Fellow from the Rohm and Haas Company where he worked for 35 years. During his employment at Rohm and Haas his responsibilities included development and management of all aspects of exposure assessment and mathematical modeling projects in the service of product safety. Dr. Jayjock is a consultant to Fortune 500 companies and government agencies including Health Canada, the European Commission, the U.S. Consumer Product Safety Commission (CPSC) and the U.S. Environmental Protection Agency (EPA). He is a Fellow of the American Industrial Hygiene Association (AIHA) and Certified by the American Board of Industrial Hygienists (ABIH) as a Certified Industrial Hygienist (CIH). He is active in various committees of the AIHA and in the publication of his research. His primary research interest includes exposure modeling of human exposure to chemicals. 

Panel Experience: Dr. Jayjock's experience on federal panels includes: Peer Review EPA Draft Exposure and Use Assessment of Five PBT Chemicals (2018); Reviewer of EPA Draft Guidelines for Human Exposure Assessment (2016); Department of Energy (DOE) Hanford Tank Vapor Assessment Team (2014); EPA peer review panel for the Draft Risk Assessment for Trichloroethylene (TCE)/Degreaser Arts/Crafts Uses (2013); EPA Science Advisory Panel on Lead Exposure (2011); the EPA Peer Consultation Panel for Perfluorooctanoic Acid (PFOA) Site-Related Environmental Assessment Program (2008); EPA Board of Scientific Councilors Peer Review Panel for the Office of Research and Development Science Program (2005); EPA Human Health Research Strategy Panel (2002); and member of or consultant to the EPA Science Advisory Board  -  Integrated Human Exposure Committee (IHEC;1998-2003).
                                       

                               Marty S. Kanarek

Affiliation: Professor, University of Wisconsin-Madison, School of Medicine and Public Health and Nelson Institute for Environmental Studies, Madison, Wisconsin

Expertise: Environmental Epidemiology.

Education: 	PhD in Epidemiology, University of California-Berkeley, Berkeley, California;		
MPH in Environmental Health, University of Minnesota, Minneapolis, Minnesota;
BA in Biology, Grinnell College, Grinnell, Iowa.

Experience Summary: Dr. Marty Kanarek has been a Professor of Environmental Epidemiology for 40 years. He teaches and does research on environmental pollutants such as PCBs, lead, mercury, asbestos and others. He has published widely on the epidemiology of asbestos and mesothelioma. He is a Fellow in the American College of Epidemiology.

Panel Experience: Dr. Kanarek has served on advisory panels to IARC, NTP, NIEHS, EPA, NIH and others. He has served on study sections at NIH and done similar for EPA. 
                               Steven Markowitz
                                       
Affiliation: Professor and Director, Barry Commoner Center for Health and the Environment, Queens College, City University of New York (CUNY) and Professor, DrPH Program, CUNY School of Public Health.

Expertise: Medical screening; asbestos-related disorders; occupational cancer. 

Education: 	DrPH and MD, Columbia University. New York, New York;
 		BA, Yale University, New Haven, Connecticut.

Experience Summary: Dr. Steven Markowitz, an occupational medicine physician, internist, and epidemiologist, is Professor and Director of the Barry Commoner Center for Health and the Environment at the City University of New York. He is Adjunct Professor of Environmental Medicine and Public Health at the Icahn School of Medicine at Mt. Sinai. Dr. Markowitz has taught and conducted research in occupational medicine and epidemiology for over 30 years. Since 2000, Dr. Markowitz has directed a low dose CT scan-based screening program for nearly 14,000 former U.S. nuclear weapons workers, the largest occupational lung cancer screening program in the country. Dr. Markowitz has published research on medical screening, asbestos-related disorders, and occupational cancer. From 2017 to 2018, he served as Editor-in-Chief of the American Journal of Industrial Medicine. He has over 100 publications in occupational medicine.

Panel Experience: Dr. Markowitz is currently Chair, Advisory Board on Toxic Substances and Worker Health, U.S. Department of Labor (2016-present) and a member of the World Trade Center Scientific and Technical Advisory Board of the National Institute for Occupational Safety and Health (2011-present). He was a member of the Board of Scientific Counselors, National Toxicology Program (2014-2017); agent-specific Expert Panel Committees, National Toxicology Program, NIEHS (2007, 2008, and 2018); Expert Panel on Lung Cancer Screening Surveillance, CDC (2013); and the World Trade Center Expert Technical Review Panel, EPA (2004-2005). Dr. Markowitz has also served on numerous State committees or boards.


                            Elizabeth A. Sheppard

Affiliation: Professor of Biostatistics and Assistant Chair in the Department of Environmental and Occupational Health Sciences at the University of Washington, Seattle, Washington.

Expertise: Understanding the health effects of environmental and occupational exposure with an emphasis on the design, measurement, and modeling of exposure for such inferences. 

Education: 	PhD in Biostatistics, University of Washington, Seattle, Washington; 
      ScM in Biostatistics, Johns Hopkins University, Baltimore, Maryland;
      BA in Psychology, Johns Hopkins University, Baltimore, Maryland.

Experience Summary: Dr. Elizabeth Sheppard is a Professor of Biostatistics, and Environmental and Occupational Health Sciences at the University of Washington. She is a Fellow of the American Statistical Association and a member of the editorial board for Epidemiology. Her research focuses on statistical methods for understanding design, measurement error, exposure modeling, and estimation of environmental and occupational exposure effects with application to a wide range of health outcomes. She actively collaborates with many principal investigators on multiple projects in the environmental and occupational health sciences and has been lead statistician for the multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) study, a 10-year study funded by EPA to determine the effect of long-term air pollution exposure on subclinical progression of cardiovascular disease. Dr. Sheppard directs an NIEHS-funded program for quantitative training in the environmental health sciences. She serves on the Health Effects Institute's Review Committee and has advised EPA through service on several Clean Air Scientific Advisory Committee special panels and Science Advisory Board ad hoc committees.

Panel Experience: Dr. Sheppard's experience on EPA panels includes chartered CASAC (2015-2018) and several CASAC Review Panels: O3 (2005-2008 and 2010-2011), NOx and SOx (2007-2010), NOx (2013-2016), SOx (2014-2018), PM (2015-2018); two IRIS Review Panels: Libby Amphibole Asbestos (2011-2013), Ethylene Oxide (2014-2015); and the FIFRA Science Advisory Panel for the Evaluation of the Carcinogenic Potential of Glyphosate (2016-2017). She has also been a member of the Health Effects Institute Review Committee, the Pesticides Advisory Committee for CAREX Canada, and the Center for Transportation, Environment, and Community Health Technical Advisory Board. She has also served on several peer review panels for NIH, NIOSH, and EPA. 

                                 Arti Shukla

Affiliation: Associate Professor, Department of Pathology, Larner College of Medicine, University of Vermont (UVM), Burlington, Vermont

Expertise: To understand the molecular mechanisms behind asbestos-induced lung diseases with special focus on malignant mesothelioma.

Education: 	PhD, MS and BS in Biochemistry from Banares Hindu University, Varanasi, UP, India

Experience Summary: Dr. Arti Shukla is Associate Professor of Pathology with 20 years of research experience on asbestos related diseases. She runs an independent research program and mentors students for MS and PhD degrees. She has 101 published papers with 5601 citations and h-index 39. She is consistently funded by Mesothelioma Applied Research Foundation (MARF), NIH or Department of Defense (DoD) grants. She has co-organized a NIEHS workshop, Asbestos Health Effects (July 31, 2017) at Davis Center, University of Vermont, served as editorial board member for four journals and reviewed grants for many national and international agencies. Her primary research interests focus on understanding the mechanisms of asbestos-induced fibrosis and mesothelioma development using in vitro and in vivo models. The main goal of her team is to identify biomarkers of asbestos exposure for early diagnosis of mesothelioma as well as to develop therapeutic strategies for treatment of mesothelioma.

Panel Experience: Dr. Shukla is constantly invited as grant reviewer for both on-line and in person meetings for various national (NIH 2009,2013,2016, 2019, 2020; CDC/NIOSH 2016 & DoD 2010, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019 ) and international agencies (Louisiana Board of Regents, 2009; Health Research Board, Dublin, Ireland, 2012; British Lung Foundation, UK 2012; European Science Foundation, 2012; Medical Research Council, UK 2013; National Science Center, Poland, 2014; Biomedical Commission, Brussels, 2016; MRC Toxicology Unit, University of Leicester, UK, 2017; Wellcome Trust/Department of Biotechnology (DBT) India Alliance, 2018). Dr. Shukla has also served on many local review panels (Lake Champlain Cancer Research Organization [LCCRO], Vermont Genetics Network [VGN]).






                                Emanuela Taioli
Affiliation: Director, Institute for Translational Epidemiology; Associate Director, Population Science; Program Director, Cancer Prevention & Control, Icahn School of Medicine at Mount Sinai, New York.

Expertise: Cancer epidemiology; environmental carcinogens, cancer and nutrition, and genetic susceptibility to cancer, genetic susceptibility to environmental exposure, cancer survivorship, health disparity, access to care in minorities, and chronic diseases prevention.

Education: 	MD, University of Milan, School of Medicine, Milan, Italy; 
		MS in Epidemiology, Columbia University, New York, New York;
		MS in Philosophy, Columbia University, New York, New York;
            PhD in Epidemiology, Columbia University, New York, New York.

Experience Summary: Dr. Emanuela Taioli is the Director of the Institute for Translational Epidemiology at the Icahn School of Medicine at Mount Sinai. She has conducted extensive research in the World Trade Center cohort. As Associate Director of Population Science, Dr. Taioli oversees the epidemiological, behavioral and health service research activities of the Tisch Cancer Institute at Mount Sinai. Dr. Taioli also co-leads the Cancer Prevention and Control Program. Among her most important contributions are those to the field of cancer prevention, including the study of cancer risk factors in healthy populations, cancer predisposing factors, hormone metabolism and genetic susceptibility to environmental exposure. She is a well-recognized expert in cancer survivorship and the effect of lifestyles changes on the risk for cancer recurrence and the development of secondary cancers. She has worked extensively on health disparities, access to care and chronic disease prevention in minority populations. She is a Scientific Board Member of the Mesothelioma Foundation, and of the Member, International Association for the Study of Lung Cancer (IASLC) Mesothelioma Task Force.

Panel Experience: Dr. Taioli is currently an ad hoc member of EPA, TSCA, SACC (2015-present). Dr. Taioli's experience on panels includes, Lung Cancer Foundation Granter review (2018-present); National Cancer Institute (NCI) Fellow Study Section (2011-present); NIH Cancer Health Disparities/Diversity in Basic Cancer Research (2011-present); NIH Specialized Programs of Research Excellence (SPORE) Special Emphasis Panel (2010-present); Permanent Member, American Cancer Society study section "Clinical Cancer Research, Nutrition and Epidemiology" (2008-present); Special Emphasis Panel NIH Study Section, Cancer Prevention (2008-present); National Institute of Environmental Health Sciences Superfund grant reviewer (2010-2013); Clinical Trials Grants review panel, Komen Foundation NY-standing member (2008-2010); EU Program VII reviewer (2004). She has been a member of the EPA, SAB Review on Trimethylbenzenes (2014), and of the EPA's SAB Polycyclic Aromatic Hydrocarbon Mixtures Review Panel (2010).


                             Bradley S. Van Gosen

Affiliation: Research Geologist, U.S. Geological Survey, Denver, Colorado.

Expertise: Applied research on the geology, geochemistry, mineralogy, and genesis of diverse types of mineral deposits and related mineral resources.

Education: 	MS in Geology, Colorado School of Mines, Golden, Colorado;
                 BA in Geology, University of Colorado, Boulder, Colorado.

Experience Summary: Mr. Bradley Van Gosen has been a Research Geologist for the U.S. Geological Survey (USGS) since 1988. He has been the lead author or co-author of 137 publications describing a variety of mineral deposit types, including metallic deposits, uranium, thorium, rare earth elements, and industrial minerals, which have included talc and asbestos. He has authored 21 publications on natural occurrences of asbestos and coauthored four others. Mr. Van Gosen has presented 18 invited talks on the geology of natural occurrences of asbestos to a variety of organizations. He serves on an advisory capacity and as a technical peer reviewer on matters of asbestos mineralogy and geology to the FDA and NIOSH. Since November 2018, Mr. Van Gosen has served on behalf of the USGS to the Interagency Working Group on Asbestos in Consumer Products, organized by the FDA. He serves as a U.S. delegate and Vice Chair for the United Nations Economic Commission for Europe (UNECE) Expert Group on Resource Classification (2011-present). He also is the U.S. member of a collaborative uranium-thorium working group of the International Atomic Energy Agency (IAEA) (2011-present).

Panel Experience: From November 2018 to present, Mr. Van Gosen has served on an advisory capacity and as a technical peer reviewer on matters of asbestos mineralogy and geology to the FDA. Mr. Van Gosen has also participated in advisory panels including: Interagency Asbestos Technical Working Group (2002 - 2004); Special Science Seminar with the CDC, National Center for Environmental Health, and ATSDR (2005); EPA Risk Assessors Training Conference (2008); and EPA Technical Review Workshop (2009).

